Literature DB >> 18571738

End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions.

Sumathi Ramachandran1, Guo-Liang Xia, Lilia M Ganova-Raeva, Omana V Nainan, Yury Khudyakov.   

Abstract

An approach for determination of hepatitis C virus (HCV) quasispecies by end-point limiting-dilution real-time PCR (EPLD-PCR) is described. It involves isolation of individual coexisting sequence variants of the hypervariable region 1 (HVR1) of the HCV genome from serum specimens using a limiting-dilution protocol. EPLD-PCR applied to an HCV outbreak study provided insights into the epidemiological relationships between incident and chronic cases. When applied to samples from a longitudinal study of infected patients, HVR1 sequences from each sampling time-point were observed to group as distinct phylogenetic clusters. Melting peak analysis conducted on EPLD-PCR products generated from these patients could be used for evaluation of HVR1 sequence heterogeneity without recourse to clonal sequencing. Further, to better understand the mechanism of single-molecule PCR, experiments were conducted under optimal and suboptimal annealing temperatures. Under all temperature conditions tested, HVR1 variants from the major phylogenetic clusters of quasispecies could be amplified, revealing that successful HVR1 quasispecies analysis is not contingent to dilution of starting cDNA preparations to a single-molecule state. It was found that EPLD-PCR conducted at suboptimal annealing temperatures generated distributions of unique-sequence variants slightly different from the distribution obtained by PCR conducted at the optimal temperature. Hence, EPLD-PCR conditions can be manipulated to access different subpopulations of HCV HVR1 quasispecies, thus, improving the range of the quasispecies detection. Although EPLD-PCR conducted at different conditions detect slightly different quasispecies populations, as was shown in this study, the resulted samples of quasispecies are completely suitable for molecular epidemiological investigation in different clinical and epidemiological settings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571738     DOI: 10.1016/j.jviromet.2008.05.005

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  29 in total

1.  Deoxyuridine in DNA has an inhibitory and promutagenic effect on RNA transcription by diverse RNA polymerases.

Authors:  Junru Cui; Anthony Gizzi; James T Stivers
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

Review 2.  Recent advances in rapid pathogen detection method based on biosensors.

Authors:  Ying Chen; Zhenzhen Wang; Yingxun Liu; Xin Wang; Ying Li; Ping Ma; Bing Gu; Hongchun Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-22       Impact factor: 3.267

3.  Robust hepatitis B virus genotyping by mass spectrometry.

Authors:  L Ganova-Raeva; S Ramachandran; C Honisch; J C Forbi; X Zhai; Y Khudyakov
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

4.  Outbreak of hepatitis C virus infection associated with narcotics diversion by an hepatitis C virus-infected surgical technician.

Authors:  Amy E Warner; Melissa K Schaefer; Priti R Patel; Jan Drobeniuc; Guoliang Xia; Yulin Lin; Yury Khudyakov; Candace W Vonderwahl; Lisa Miller; Nicola D Thompson
Journal:  Am J Infect Control       Date:  2014-11-20       Impact factor: 2.918

5.  Simultaneous cocirculation of both European varicella-zoster virus genotypes (E1 and E2) in Mexico city.

Authors:  Araceli Rodríguez-Castillo; Gilberto Vaughan; José Ernesto Ramírez-González; Alejandro Escobar-Gutiérrez
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

6.  Hepatitis C virus infection among people who inject drugs in Bangkok, Thailand, 2005-2010.

Authors:  Michael Martin; Suphak Vanichseni; Wanna Leelawiwat; Rapeepan Anekvorapong; Boonyos Raengsakulrach; Thitima Cherdtrakulkiat; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Janet M McNicholl; Somyot Kittimunkong; Marcel E Curlin; Kachit Choopanya
Journal:  WHO South East Asia J Public Health       Date:  2019-04

Review 7.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

8.  Rapid hepatitis C virus divergence among chronically infected individuals.

Authors:  Mayra Cruz-Rivera; Juan Carlos Carpio-Pedroza; Alejandro Escobar-Gutiérrez; Daniela Lozano; Arely Vergara-Castaneda; Pilar Rivera-Osorio; Armando Martinez-Guarneros; Carlos A Vazquez Chacon; Salvador Fonseca-Coronado; Gilberto Vaughan
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

9.  Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria.

Authors:  Joseph C Forbi; Gilberto Vaughan; Michael A Purdy; David S Campo; Guo-liang Xia; Lilia M Ganova-Raeva; Sumathi Ramachandran; Hong Thai; Yury E Khudyakov
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

10.  A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy.

Authors:  Matthew J Akiyama; Daniel Lipsey; Lilia Ganova-Raeva; Lili T Punkova; Linda Agyemang; Amanda Sue; Sumathi Ramachandran; Yury Khudyakov; Alain H Litwin
Journal:  J Infect Dis       Date:  2020-07-06       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.